Evidence map›Paper›PMID 31860871›Full record

ArticleAging2019

Identification of breast cancer risk modules via an integrated strategy.

Wan Li, Gui Deng, Ji Zhang, Erqiang Hu, Yuehan He, Junjie Lv, Xilin Sun, Kai Wang, Lina Chen

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Non-Coding RNAs Extended Omnigenic Module of Cancers.Entropy (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wan LiCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Gui DengCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Ji ZhangCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Erqiang HuCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Yuehan HeCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Junjie LvCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Xilin SunMolecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, China.
Kai WangMolecular Imaging Research Center (MIRC), Harbin Medical University, Harbin, China.
Lina ChenCollege of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Harbin Medical University · CNFourth Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the most common malignant cancers among females worldwide. This complex disease is not caused by a single gene, but resulted from multi-gene interactions, which could be represented by biological networks. Network modules are composed of genes with significant similarities in terms of expression, function and disease association. Therefore, the identification of disease risk modules could contribute to understanding the molecular mechanisms underlying breast cancer. In this paper, an integrated disease risk module identification strategy was proposed according to a multi-objective programming model for two similarity criteria as well as significance of permutation tests in Markov random field module score, function consistency score and Pearson correlation coefficient difference score. Three breast cancer risk modules were identified from a breast cancer-related interaction network. Genes in these risk modules were confirmed to play critical roles in breast cancer by literature review. These risk modules were enriched in breast cancer-related pathways or functions and could distinguish between breast tumor and normal samples with high accuracy for not only the microarray dataset used for breast cancer risk module identification, but also another two independent datasets. Our integrated strategy could be extended to other complex diseases to identify their risk modules and reveal their pathogenesis.

Indexed as

Genetic Predisposition to DiseaseModels, GeneticSoftwareAlgorithmsBreast NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansRisk Factorsbreast cancerdisease risk moduleintegrated strategymulti-objective programming modelpermutation test

Identifiers

PMID31860871
PMCPMC6949069
OpenAlexW2996476962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.